Omnicef 1 g Injection Vial

Composition of Omnicef 1 g Injection Vial

Omnicef 1 g Injection Vial contains Ceftriaxone 1 g (as ceftriaxone sodium) powder for injection. It belongs to the Third-generation cephalosporin (beta-lactam antibiotic) class of medicines.

Uses of Omnicef 1 g Injection Vial

• Treatment of susceptible bacterial infections such as pneumonia and other respiratory tract infections
• urinary tract infections
• typhoid fever
• intra‑abdominal infections
• skin/soft tissue infections
• bone and joint infections
• gonorrhoea
• septicaemia
• meningitis; perioperative surgical prophylaxis

Key benefits

• Broad-spectrum treatment of serious bacterial infections
• Effective in respiratory and urinary tract infections
• Used in typhoid fever and gonorrhoea
• Useful for meningitis and sepsis
• Option for surgical infection prophylaxis

How Omnicef 1 g Injection Vial works

Ceftriaxone is a third‑generation cephalosporin antibiotic. It kills bacteria by inhibiting bacterial cell wall synthesis through binding to penicillin‑binding proteins, leading to cell lysis.

How to take Omnicef 1 g Injection Vial

Take exactly as prescribed by your doctor.

Side effects of Omnicef 1 g Injection Vial

Most side effects of Omnicef are mild and settle as the body adjusts. Reported side effects include:

• Injection site pain/swelling
• diarrhoea
• nausea
• vomiting
• abdominal pain
• rash
• itching
• headache
• dizziness
• raised liver enzymes
• eosinophilia

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Omnicef 1 g Injection Vial

Warnings and precautions

Prescription-only antibiotic; use only for bacterial infections. Do not use if allergic to ceftriaxone/cephalosporins; caution in severe penicillin allergy. Risk of C. difficile-associated diarrhoea; seek care for severe/persistent diarrhoea. Avoid/contraindicated in hyperbilirubinaemic neonates and in neonates receiving IV calcium-containing solutions (risk of precipitation). Use caution in liver disease, renal impairment (especially combined), history of colitis, gallbladder/biliary sludging. Long-term use may cause superinfection; monitor CBC and liver/renal function if prolonged therapy.

Do not take Omnicef if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for anyone with a known allergy to cephalosporin antibiotics.

Interactions with other medicines

Calcium-containing IV solutions in neonates (contraindicated) and avoid mixing with calcium solutions in the same IV line; warfarin/other anticoagulants (increased bleeding risk—monitor INR); aminoglycosides/loop diuretics (increased nephrotoxicity risk—monitor); oral typhoid vaccine (reduced efficacy); probenecid (may increase cephalosporin levels)

How to store Omnicef 1 g Injection Vial

Store unopened vial at or below 25°C, protected from light and moisture. After reconstitution, use as per label/clinical guidelines; do not freeze reconstituted solution unless specified by manufacturer.

Expert advice for Omnicef 1 g Injection Vial

Space the doses evenly and complete the course. Keep the reconstituted syrup as the pharmacist instructed and discard it after the stated number of days.

Manufacturer and class

Manufacturer:

ARISTO PHARMACEUTICALS PVT LTD

Therapeutic class:

Antibiotic

Drug class:

Third-generation cephalosporin (beta-lactam antibiotic)